Vascular endothelial growth factor-A enhances indoleamine 2,3-dioxygenase expression by dendritic cells and subsequently impacts lymphocyte proliferation
Dendritic cells (DCs) are antigen (Ag)-presenting cells that activate and stimulate effective immune responses by T cells, but can also act as negative regulators of these responses and thus play important roles in immune regulation. Pro-angiogenic vascular endothelial growth factor (VEGF) has been...
Main Authors: | Marti, Luciana Cavalheiro, Pavon, Lorena, Severino, Patricia, Sibov, Tatiana, Guilhen, Daiane, Moreira-Filho, Carlos Alberto |
---|---|
Format: | Online |
Language: | English |
Published: |
Instituto Oswaldo Cruz
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005532/ |
Similar Items
-
Targeting the indoleamine 2,3-dioxygenase pathway in cancer
by: Moon, Yong Wha, et al.
Published: (2015) -
Expression Pattern and Clinicopathological Relevance of the Indoleamine 2,3-Dioxygenase 1/Tryptophan 2,3-Dioxygenase Protein in Colorectal Cancer
by: Chen, I-Chien, et al.
Published: (2016) -
The role of indoleamine 2,3-dioxygenase in modulating allergic responses
by: Salazar, F.
Published: (2016) -
Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
by: Ferdinande, L, et al.
Published: (2012) -
Natural CD4+ T-Cell Responses against Indoleamine 2,3-Dioxygenase
by: Munir, Shamaila, et al.
Published: (2012)